@article{48b3846dca5a4cfe9a32e27eb30e861a,
title = "Primary and Metastatic Pancreatic Cancer Cells Exhibit Differential Migratory Potentials",
abstract = "Objectives Pancreatic ductal adenocarcinoma (PDAC) is characterized by early metastatic spread in more than 50% of patients. In this study, we sought to understand the migratory properties of (non)metastatic PDAC cells and determine whether the migration of cancer stem cell (CSC) populations accounts for the aggressive nature of this disease. Methods The migratory abilities of primary and metastatic PDAC cell lines were investigated using a microfluidic device and time-lapse photography. The velocity, time of delay of mobilization, and number of migratory cells were analyzed. Cancer stem cell subpopulations were isolated by fluorescence-activated cell sorting and their migratory properties compared with their non-CSC counterparts. Results Primary cancer cells exhibited higher velocities, greater number of migratory cells, and a shorter time of delay of mobilization in comparison to metastatic cell lines. Characterization of CSC populations revealed primary PDAC cell lines were composed of fewer CD133+ and CD24+CD44+ CSC subpopulations than metastatic cells. Moreover, migratory analysis of CSC subpopulations revealed lower velocities, fewer migratory cells, and a greater time of delay of mobilization than non-CSC. Conclusions Primary cancer cells demonstrate enhanced migratory abilities in comparison to metastatic PDAC cells. Those differences may result from lower CSC subpopulations in primary cells because CSC populations demonstrated impaired migratory abilities in contrast to non-CSC.",
keywords = "CD133, metastasis, migration, pancreatic cancer, stem cells",
author = "Park, {Joo Kyung} and Thomas Hank and Scherber, {Cally M.} and Lillemoe, {Keith D.} and {Fern{\'a}ndez-Del Castillo}, Carlos and Warshaw, {Andrew L.} and Mehmet Toner and Daniel Irimia and Thayer, {Sarah P.} and Liss, {Andrew S.}",
note = "Funding Information: From the Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA. Received for publication June 5, 2019; accepted November 7, 2019. Address correspondence to: Andrew S. Liss, PhD, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114 (e‐mail: ALiss@mgh.harvard.edu). J.K.P. and T.H. contributed equally to this work. This work was supported in part by a grant from the National Institutes of Health (R21CA135601). All microfabrication was performed at the BioMEMS Resource Center, supported by a grant from the National Institutes of Health (P41EB002503). T.H. is funded by a Mildred-Scheel-Postdoctoral Fellowship from German Cancer Aid. The authors declare no conflict of interest. J.K.P. is now with the Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. S.P.T. is now with Fred and Pamela Buffett Cancer Center, Division of Surgical Oncology, University of Nebraska Medical Center, Omaha, NE. Supplemental digital contents are available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal{\textquoteright}s Web site (www.pancreasjournal.com). Copyright {\textcopyright} 2019 Wolters Kluwer Health, Inc. All rights reserved. DOI: 10.1097/MPA.0000000000001459 Publisher Copyright: {\textcopyright} 2020 Wolters Kluwer Health, Inc. All rights reserved.",
year = "2020",
month = jan,
day = "1",
doi = "10.1097/MPA.0000000000001459",
language = "English (US)",
volume = "49",
pages = "128--134",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "1",
}